Medical Technology Manufacturers Rely on ASYS as their Development Partner with Simultaneous Engineering
We are a leading supplier of automation solutions for the electronics industry. We are also a supplier for the life science industry since many years. Our systems produce medical technology that is used for many common diseases, such as diabetes monitoring.
In order to enable people with diabetes to enjoy a higher quality of life, sensor technology has been available on the market for several years now that enables permanent and complete monitoring of the blood sugar level. The measurement probes of the sensors are applied subcutaneously for example every two weeks and remain on the body, even during sports or bathing. A small evaluation device, similar to a smartphone, collects the data by wireless if required, provides information and shows trends on how much insulin the patient needs and at which time.
The electronics for the sensor technology for this have been produced on our ASYS systems for years. Since a maximum of cleanliness is essential here, the benefits are cut with laser technology in our POLYPHOS DP 8000 and POLYPHOS DP 9000 laser depaneling machines. This offers high safety and quality and, with cycle times of < 900 milliseconds per individual circuit, is also even faster and gentler for the switching of the blood sugar sensor. Also the complete handling, the execution of the function tests and the programming of the circuit is automated on our lines.
In the meantime, we have installed several systems for this purpose in Europe and the USA, and further systems are currently being planned for the major medical technology manufacturers. As the demand is growing and the technology is developing rapidly, further systems with even smaller and more inconspicuous sensors are under development. They provide even more accurate data and further increase user-friendliness.
Also in this area, medical technology manufacturers rely on ASYS as their development partner with simultaneous engineering. Because the economical production of the sensor technology and the flawless function through the fully automated process ensures that these solutions can be made available to a large number of patients. Due to the short development cycles of sensor technology and the rapid further development of solutions, reliable partners with know-how in the electronics and GMP area are essential. With our broad portfolio and deep expert know-how, we are perfectly positioned to handle projects with this requirement profile.
Diabetes mellitus, in short diabetes or commonly known as diabetes, is a metabolic disorder of the carbohydrate metabolism, which is based on a lack of insulin and leads to chronic hyperglycaemia. Every two years, the International Diabetes Federation publishes new data on the worldwide spread of diabetes. The current figures show that the metabolic disease is still on the rise. Currently, approximately 425 million adults worldwide (one in eleven) have diabetes, of which more than 90 percent have type 2 diabetes. Estimates and projections assume that 700 million people will be affected by diabetes by 2045. About 350 million people have an increased risk of type 2 diabetes.